Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs sufentanil vs methadone for postoperative pain and delirium after spinal surgery
IRCT20221218056854N1Phase 3Completed
- Sponsor
- Ilam University of Medical Sciences
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of remifentanil, sufentanil and methadone in postoperative pain and postoperative delirium (POD) (3 arms), sponsored by Ilam University of Medical Sciences. Primary endpoints: Pain score, Delirium duration and 1 more. Started Jan 2023; status: completed.
02
Drugs
remifentanilsufentanilmethadone
03
Conditions
postoperative painpostoperative delirium (POD)
Beyond the preview
Go deeper on IRCT20221218056854N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221218056854N1.